Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1649]
News [6505]
Articles [99]
Editorials [4]
Conferences [186]
elearning [21]
Choosing Wisely in pathology
Dr Angela Mlole - Ocean Road Cancer Institute, Dar es Salaam, Tanzania
Choosing Wisely in pathology ( Dr Angela Mlole - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )
18 May 2023
Choosing Wisely in radiology Tanzania
Dr Revelian Iramu - Ocean Road Cancer Institute, Dar es Salaam, Tanzania
Choosing Wisely in radiology Tanzania ( Dr Revelian Iramu - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )
18 May 2023
The HypoAfrica study and AC3T research partnerships at NLCC
Dr Adedayo Joseph - NSIA-LUTH Cancer Center, Lagos, Nigeria
The HypoAfrica study and AC3T research partnerships at NLCC ( Dr Adedayo Joseph - NSIA-LUTH Cancer Center, Lagos, Nigeria )
17 May 2023
Collective efforts to combat cancer in Cambodia
Her Excellency Dr Or Vandine - Secretary of State, Ministry of Health, Cambodia
Collective efforts to combat cancer in Cambodia ( Her Excellency Dr Or Vandine - Secretary of State, Ministry of Health, Cambodia )
5 May 2023
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast...
Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German )
2 May 2023
TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small...
Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany
TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany )
2 May 2023
The use of IORT at Universitätsmedizin Mannheim hospital
Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany
The use of IORT at Universitätsmedizin Mannheim hospital ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany )
2 May 2023
Applying the syndemic framework to cancer research for effective cancer control...
Dr Zahid Butt - University of Waterloo, Waterloo, Canada
Applying the syndemic framework to cancer research for effective cancer control in LMICs ( Dr Zahid Butt - University of Waterloo, Waterloo, Canada )
27 Apr 2023
Li-Fraumeni syndrome-associated dimer-forming mutant p53 promotes...
Dr Joshua Choe - Columbia University, New York City, USA
Li-Fraumeni syndrome-associated dimer-forming mutant p53 promotes transactivation-independent mitochondrial cell death ( Dr Joshua Choe - Columbia University, New York City, USA )
27 Apr 2023
Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity...
Dr Luis Paz-Ares - Hospital Universitario 12 de Octubre, Madrid, Spain
Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity for patients with nonsquamous NSCLC ( Dr Luis Paz-Ares - Hospital Universitario 12 de Octubre, Madrid, Spain )
26 Apr 2023
CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC...
Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA
CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC/GEJC/EAC ( Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA )
26 Apr 2023
Initial results from a phase 1 dose escalation trial of E-602 shows efficacy in...
Dr Jason Luke - University of Pittsburgh, Pittsburgh, USA
Initial results from a phase 1 dose escalation trial of E-602 shows efficacy in solid tumours ( Dr Jason Luke - University of Pittsburgh, Pittsburgh, USA )
26 Apr 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation